HALIFAX, Nova Scotia, Feb. 11, 2019 /PRNewswire/ -- Densitas, Inc., a breast imaging analytics innovator based in Halifax, Nova Scotia, today announces a new collaboration partnership with TeleMammography Specialists of Decatur, Georgia. TeleMammography Specialists will be the first U.S. beta user for the new densitasquality™ solution from Densitas, which will be used to improve the communications and information sharing needed to meet EQUIP guidelines. TeleMammography Specialists will also implement the recently released densitasdensity™ automated breast density assessment software. Densitas personnel will be available in Booth #4093 at this week's HIMSS Annual Meeting to discuss the benefits and capabilities of these solutions.
"densitasquality™ supports effective and efficient delivery of enterprise-wide mammography quality assurance. Our goal is to provide tools that reduce the documentation, process and communication burdens of meeting EQUIP guidelines and enables sustainable delivery of quality assurance across the mammography enterprise," says Mohamed Abdolell, CEO of Densitas. "We understand that quality improvement requires a comprehensive solution that addresses the complexity of breast screening and enables identification of root causes of variation in screening processes. Delivering consistently high quality care requires tools that provide standardized and reliably reproducible measures of quality that can be continuously monitored and evaluated."
TeleMammography Specialists, LLC. is an international teleradiology services provider that is specialized in breast imaging. Densitas Quality will help:
By making densitasquality™ and densitasdensity™ available to all of TeleMammography Specialists clients, over 60,000 women will benefit annually. "Densitas will help us provide consistent quality and standardize density assessment among our Radiologists", says Martha H. Garrison, MD., President and CEO of TeleMammography Specialists, LLC. "We will be able to more proactively manage the needs of our clients and provide consistently high quality of care."
The A.I. powered densitasdensity™ software delivers fully automated, standardized, and reliably reproducible breast density assessment. Additionally, densitasdensity™ results can be incorporated in risk models to generate standardized and reliably reproducible breast cancer risk assessment.
Densitas' vision is to move the needle in breast cancer screening through tailored patient management for sustainable healthcare service delivery and improved outcomes. Densitas develops advanced breast imaging analytics technologies powered by machine learning with the goal to deliver on-demand actionable insights that improve the quality of breast health management. Our products tackle the key challenges facing breast imaging today, including mammography quality, workflow efficiencies, compliance with national guidelines, and delivery of appropriate care at sustainable costs. Learn more at www.densitas.health